Nicole Urban

Nicole Urban

Auto-generated profile, based on publicly available information

Nicole Urban

Rudolf-Boehm-Institute of Pharmacology and Toxicology, Leipzig University, Leipzig, Germany

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 April 2018 in ChemMedChem
Verified
Journal Article
Closed access
PDF file
SHStephanie Häfner
Stephanie Häfner
FBFinn Burg
Finn Burg
MKMartina Kannler
Martina Kannler
NUNicole Urban
Nicole Urban
PMPeter Mayer
Peter Mayer
MSMichael Schaefer
Michael Schaefer

1 January 2021 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
CLCharlotte Leser
Charlotte Leser
MKMarco Keller
Marco Keller
SGSusanne Gerndt
Susanne Gerndt
NUNicole Urban
Nicole Urban
CCCheng-Chang Chen
Cheng-Chang Chen
Franz BracherFranz Bracher
Franz Bracher

1 September 2017 in Cell Calcium
Verified
Journal Article
Closed access
HBHolger Beckmann
Holger Beckmann
JRJulia Richter
Julia Richter
KHKerstin Hill
Kerstin Hill
NUNicole Urban
Nicole Urban
HLHorst Lemoine
Horst Lemoine
MSMichael Schaefer
Michael Schaefer


14 January 2020 in Cells
Verified
Journal Article
Open access
PDF file
NUNicole Urban
Nicole Urban
MSMichael Schaefer
Michael Schaefer
(1) Background: Members of the TRPC3/TRPC6/TRPC7 subfamily of canonical transient receptor potential (TRP) channels share an amino acid similarity of more than 80% and can form heteromeric channel complexes. They are directly gated by diacylglycerols in a protein kinase C-independent manner. To assess TRPC3 channel functions without concomitant protein kinase C activation, direct activators are highly desirable. (2) Methods: By screening 2000 bioactive compounds in a Ca2+ influx assay, we identified artemisinin as a TRPC3 activator. Validation and characterization of the hit was performed by applying fluorometric Ca2+ influx assays and electrophysiological patch-clamp experiments in heterologously or endogenously TRPC3-expressing cells. (3) Results: Artemisinin elicited Ca2+ entry through TRPC3 or heteromeric TRPC3:TRPC6 channels, but did not or only weakly activated TRPC6 and TRPC7. Electrophysiological recordings confirmed the reversible and repeatable TRPC3 activation by artemisinin that was inhibited by established TRPC3 channel blockers. Rectification properties and reversal potentials were similar to those observed after stimulation with a diacylglycerol mimic, indicating that artemisinin induces a similar active state as the physiological activator. In rat pheochromocytoma PC12 cells that endogenously express TRPC3, artemisinin induced a Ca2+ influx and TRPC3-like currents. (4) Conclusions: Our findings identify artemisinin as a new biologically active entity to activate recombinant or native TRPC3-bearing channel complexes in a membrane-confined fashion.

1 January 2022 in European Journal of Pharmacology
Verified
Journal Article
Closed access
YBYannik Bluhm
Yannik Bluhm
RRRick Raudszus
Rick Raudszus
AWAnne Wagner
Anne Wagner
NUNicole Urban
Nicole Urban
MSMichael Schaefer
Michael Schaefer
KHKerstin Hill
Kerstin Hill